Skip to main content
Clinical Trials/NCT01874106
NCT01874106
Completed
Not Applicable

Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients

Maryam Ekramzadeh, PhD1 site in 1 country120 target enrollmentOctober 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammation
Sponsor
Maryam Ekramzadeh, PhD
Enrollment
120
Locations
1
Primary Endpoint
Change in serum Albumin
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effect of especial diet therapy "Anti-inflammatory Diet" on inflammatory, oxidative stress, and nutritional markers in the context of protein-energy wasting syndrome(PEW) in hemodialysis patients.

Registry
clinicaltrials.gov
Start Date
October 2012
End Date
August 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Maryam Ekramzadeh, PhD
Responsible Party
Sponsor Investigator
Principal Investigator

Maryam Ekramzadeh, PhD

PhD

Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients who are on hemodialysis(HD) at least two times a week for 3months or more without any internment illness or admission

Exclusion Criteria

  • Hospitalization because of sepsis or surgery 3 months prior to intervention
  • Cirrhosis
  • Hepatitis virus infection
  • Human Immunodeficiency virus infection
  • Acquired Immunodeficiency Syndrome
  • Active malignancy
  • Active infection
  • Absence of communication
  • Mental Impairment
  • Terminal illness

Outcomes

Primary Outcomes

Change in serum Albumin

Time Frame: 10 weeks

Secondary Outcomes

  • Change in Subjective Global Assessment (SGA) score(10 weeks)
  • Change in Malnutrition-inflammation score(MIS)(10 weeks)
  • Change in serum C-Reactive Protein(CRP)(10 weeks)
  • Change in serum malondialdehyde(MDA)(10 weeks)
  • Change in serum Interleukin-6(IL-6)(10 weeks)
  • Change in serum total antioxidant capacity(TAC)(10 weeks)
  • Change in serum ferritin(10 weeks)
  • Change in serum total iron binding capacity(TIBC)(10 weeks)
  • Change in serum urea nitrogen(10 weeks)
  • Change in serum creatinine(10 weeks)
  • Change in serum phosphorus(10 weeks)
  • Change in body fat mass index(BFMI)(10 weeks)
  • Change in fat free mass index(FFMI)(10 weeks)
  • Change in body cell mass(BCM)(10 weeks)

Study Sites (1)

Loading locations...

Similar Trials